Literature DB >> 9335955

Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids?

F Parhami1, L L Demer.   

Abstract

Although vascular calcification is present in the vast majority of those aged over 70 years and causes serious cardiovascular dysfunction, strategies for its prevention and effective management are currently not available because the mechanism of its pathogenesis is unknown. Recently, similarities between mineralization in the vessel wall and in bone have been recognized. In this review, current understanding of the mechanisms involved in atherosclerotic calcification is summarized. In addition, several observations that may explain the paradox of vascular calcification in the face of osteoporosis are noted, emphasizing the possible role of lipid oxidation products.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9335955     DOI: 10.1097/00041433-199710000-00010

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  7 in total

1.  The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis.

Authors:  Nicole E Jensky; Joseph A Hyder; Matthew A Allison; Nathan Wong; Victor Aboyans; Roger S Blumenthal; Pamela Schreiner; J Jeffrey Carr; Christina L Wassel; Joachim H Ix; Michael H Criqui
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women.

Authors:  Mika Yamauchi; Toru Yamaguchi; Kiyoko Nawata; Ken-ichiro Tanaka; Shin Takaoka; Toshitsugu Sugimoto
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

3.  osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Authors:  N Bucay; I Sarosi; C R Dunstan; S Morony; J Tarpley; C Capparelli; S Scully; H L Tan; W Xu; D L Lacey; W J Boyle; W S Simonet
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 4.  Role of RANKL and RANK in bone loss and arthritis.

Authors:  D Holstead Jones; Y-Y Kong; J M Penninger
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 5.  Clinical, cellular, and molecular aspects of arterial calcification.

Authors:  Raul J Guzman
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

6.  Role of RANKL-RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications.

Authors:  Sarvraj Singh Kohli; Virinder Singh Kohli
Journal:  Indian J Endocrinol Metab       Date:  2011-07

7.  Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.

Authors:  H Min; S Morony; I Sarosi; C R Dunstan; C Capparelli; S Scully; G Van; S Kaufman; P J Kostenuik; D L Lacey; W J Boyle; W S Simonet
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.